Pacific Biosciences Of California, Inc. (PACB) - Comprehensive Stock Analysis & Investment Research
Deep dive into Pacific Biosciences Of California, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Pacific Biosciences Of California, Inc. Investment Summary
When evaluating whether Pacific Biosciences Of California, Inc. (PACB) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Pacific Biosciences Of California, Inc. (PACB) operates within the Industrial Applications and Services sector, specifically in the Laboratory Analytical Instruments industry. . With a market capitalization of $422 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.
Financial Performance Analysis
Our comprehensive financial analysis covers Pacific Biosciences Of California, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Pacific Biosciences Of California, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Pacific Biosciences Of California, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Pacific Biosciences Of California, Inc. (Stock Symbol: PACB) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Laboratory Analytical Instruments industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Pacific Biosciences Of California, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Pacific Biosciences Of California, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Pacific Biosciences Of California, Inc....
Revenue & Growth Analysis
Pacific Biosciences Of California, Inc. generates annual revenues of $160 million , representing an emerging company in its growth phase.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Pacific Biosciences Of California, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Pacific Biosciences Of California, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Pacific Biosciences Of California, Inc....
Strategic Market Position
Pacific Biosciences Of California, Inc. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.
Industry Competitive Landscape
Pacific Biosciences Of California, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company currently shows negative free cash flow of $-116 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Margin & Pricing Power Analysis
The company maintains a 74.9% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Asset Utilization Efficiency
Asset turnover ratio of 0.20x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 5.65 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.